Arrhythmogenic right ventricular dysplasia

Displasia arritmogénica del ventrículo derecho

Arrhythmogenic right ventricular dysplasia (ARVD) is a cardiomyopathy inherited in an autosomal dominant pattern characterized by replacement of myocytes with fibrofatty tissue. ARVD is the second cause of sudden death in young adults and accounts for a great proportion of deaths in athletes. Clinical presentation is variable, it may occur during rest or after physical activity involving unspecific symptoms such as palpitations, syncope and chest pain. We here report three autopsy cases, referred from various healthcare institutions, in which sudden death was the first manifestation.

1. McGregor SM, Husain AN. A Brief Review and Update of the Clinicopathologic Diagnosis of Arrhythmogenic Cardiomyopathy. Archives of pathology & laboratory medicine. 2015;139(9):1181-6. Epub 2015/09/01.
2. Thiene G, Corrado D, Basso C. Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Orphanet journal of rare diseases. 2007;2:45. Epub 2007/11/16.
3. Wei J, Tang J, Xia L, Chen X, Wang DW. A case of arrhythmogenic right ventricular cardiomyopathy without arrhythmias. Diagnostic pathology. 2012;7:67. Epub 2012/06/14.
4. Munkholm J, Andersen CB, Ottesen GL. Plakoglobin: a diagnostic marker of arrhythmogenic right ventricular cardiomyopathy in forensic pathology? Forensic science, medicine, and pathology. 2015;11(1):47- 52. Epub 2015/01/01.
5. Kondo T. A case of arrhythmogenic right ventricular cardiomyopathy (ARVC/D) in which tenascin C immunostaining made the assessment of myocardial remodeling possible. Soudni lekarstvi. 2014;59(3):24-5. Epub 2014/09/05.
6. Marcus FI, Fontaine GH, Guiraudon G, Frank R, Laurenceau JL, Malergue C, et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation. 1982;65(2):384-98. Epub 1982/02/01.
7. Protonotarios N, Tsatsopoulou A. Naxos disease and Carvajal syndrome: cardiocutaneous disorders that highlight the pathogenesis and broaden the spectrum of arrhythmogenic right ventricular cardiomyopathy. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology. 2004;13(4):185-94. Epub 2004/06/24.
8. Orgeron GM, Calkins H. Advances in the Diagnosis and Management of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. Current cardiology reports. 2016;18(6):53. Epub 2016/04/25.
9. Sen-Chowdhry S, Syrris P, Ward D, Asimaki A, Sevdalis E, McKenna WJ. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation. 2007;115(13):1710-20. Epub 2007/03/21.
10. Ermakov S, Scheinman M. Arrhythmogenic Right Ventricular Cardiomyopathy - Antiarrhythmic Therapy. Arrhythmia & electrophysiology review. 2015;4(2):86-9. Epub 2016/02/03.
11. Munkholm J, Christensen AH, Svendsen JH, Andersen CB. Usefulness of immunostaining for plakoglobin as a diagnostic marker of arrhythmogenic right ventricular cardiomyopathy. The American journal of cardiology. 2012;109(2):272-5. Epub 2011/11/01.